122
Views
1
CrossRef citations to date
0
Altmetric
Original Research

A Novel Risk-Scoring Model for Prediction of Premalignant and Malignant Lesions of Uterine Endometrium Among Symptomatic Premenopausal Women

ORCID Icon, , , , & ORCID Icon
Pages 883-891 | Published online: 27 Oct 2020

References

  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
  • Uterine Cancer: Statistics. Available from: https://www.cancer.net/cancer-types/uterine-cancer/statistics. Accessed September 30, 2020.
  • Lacey JV, Ioffe OB, Ronnett BM, et al. Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan. Br J Cancer. 2008;98(1):45–53.
  • Sobczuk K, Sobczuk A. New classification system of endometrial hyperplasia WHO 2014 and its clinical implications. Prz Menopauzalny. 2017;16(3):107–111. doi:doi:10.5114/pm.2017.70589
  • Trimble CL, Kauderer J, Zaino R, et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer. 2006;106(4):812–819. doi:10.1002/cncr.21650
  • Constantine GD, Kessler G, Graham S, Goldstein SR. Increased incidence of endometrial cancer following the women’s health initiative: an assessment of risk factors. J Womens Health (Larchmt). 2019;28(2):237–243. doi:10.1089/jwh.2018.6956
  • Cote ML, Ruterbusch JJ, Olson SH, et al. The growing burden of endometrial cancer: a major racial disparity affecting black women. Cancer Epidemiol Biomarkers Prev. 2015;24(9):1407–1415. doi:10.1158/1055-9965.EPI-15-0316
  • Renehan AG, Soerjomataram I, Tyson M, et al. Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer. 2010;126(3):692–702. doi:10.1002/ijc.24803
  • Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86. doi:10.1002/ijc.29210
  • Wise MR, Jordan V, Lagas A, et al. Obesity and endometrial hyperplasia and cancer in premenopausal women: a systematic review. Am J Obstet Gynecol. 2016;214(6):689.e1–e17.
  • Farquhar CM, Lethaby A, Sowter M, Verry J, Baranyai J. An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding. Am J Obstet Gynecol. 1999;181(3):525–529. doi:10.1016/S0002-9378(99)70487-4
  • Early detection, diagnosis and staging of endometrial cancer. Available from: https://www.cancer.org/cancer/endometrial-cancer/detection-diagnosis-staging/signs-and-symptoms.html. Accessed September 30, 2020.
  • ACOG Committee on Practice Bulletins-Gynecology. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: management of anovulatory bleeding. Int J Gynaecol Obstet. 2001;72(3):263–271.
  • Sweet MG, Schmidt-Dalton TA, Weiss PM, Madsen KP. Evaluation and management of abnormal uterine bleeding in premenopausal women. Am Fam Physician. 2012;85(1):35–43.
  • Disaia P, Creasman W. Adenocarcinoma of the Uterus. Clinical Gynecologic Oncology. 7th ed. 2007:147–184.
  • Royal College of Obstetricians and Gynaecologists. Standards for Gynaecology: Report of a Working Party. London. 2008 June; 1–56.
  • National Institute for Health and Clinical Excellence. Heavy Menstrual Bleeding: Assessment and Management. NICE Guideline; 2018.
  • American College of Obstetricians and Gynecologists. Diagnosis of abnormal uterine bleeding in reproductive-aged women. Pract Bull. 2012;128:197–206.
  • Gardner IA, Greiner M. Receiver-operating characteristic curves and likelihood ratios: improvements over traditional methods for the evaluation and application of veterinary clinical pathology tests. Vet Clin Pathol. 2006;35(1):8–17. doi:10.1111/j.1939-165X.2006.tb00082.x
  • Wiegand RE. Performance of using multiple stepwise algorithms for variable selection. Stat Med. 2010;29(15):1647–1659.
  • Wang D, Zhang W, Bakhai A. Comparison of Bayesian model averaging and stepwise methods for model selection in logistic regression. Stat Med. 2004;23(22):3451–3467. doi:10.1002/sim.1930
  • Labarère J, Bertrand R, Fine MJ. How to derive and validate clinical prediction models for use in intensive care medicine. Intensive Care Med. 2014;40(4):513–527. doi:10.1007/s00134-014-3227-6
  • Osborne JW. Prediction in multiple regression. Pract Assessment Res Eval. 2000;7:2. doi:10.7275/7j20-gg86
  • Pennant ME, Mehta R, Moody P, et al. Premenopausal abnormal uterine bleeding and risk of endometrial cancer. BJOG. 2017;124(3):404–411. doi:10.1111/1471-0528.14385
  • Guraslan H, Dogan K, Kaya C, et al. Could body mass index be an indicator for endometrial biopsy in premenopausal women with heavy menstrual bleeding? Arch Gynecol Obstet. 2016;294(2):395–402. doi:10.1007/s00404-016-4043-8
  • Corbacioglu Esmer O, Akbayir BPC, Goksedef, et al. Is there an appropriate cutoff age for sampling the endometrium in premenopausal bleeding? Gynecol Obstet Invest. 2014;77(1):40–44. doi:10.1159/000356959
  • Gawron ML, Babczyk D, et al. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling. Przegl Lek. 2017;74(4):139–143.
  • Iram S, Musonda P, Ewies AA. Premenopausal bleeding: when should the endometrium be investigated? —a retrospective non-comparative study of 3006 women. Eur J Obstet Gynecol Reprod Biol. 2010;148(1):86–89. doi:10.1016/j.ejogrb.2009.09.023
  • Wise MR, Gill P, Lensen S, Tompson JMD, Farquhar CM. Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women. Am J Obstet Gynecol. 2016;215(5):598–598.e8. doi:10.1016/j.ajog.2016.06.006
  • Giannella L, Cerami LB, Setti T, Bergamini E, Boselli F. Prediction of endometrial hyperplasia and cancer among premenopausal women with abnormal uterine bleeding. Biomed Res Int. 2019;2019:1–6. doi:10.1155/2019/8598152
  • Ozdemir S, Celik C, Gezginc K, Kiresi D, Esen H. Evaluation of endometrial thickness with transvaginal ultrasonography and histopathology in premenopausal women with abnormal vaginal bleeding. Arch Obstet Gynecol. 2010;282(4):395–399. doi:10.1007/s00404-009-1290-y
  • Getpook C, Wattanakumtornkul S. Endometrial thickness screening in premenopausal women with abnormal uterine bleeding. J Obstet Gynaecol Res. 2006;32(6):588–592. doi:10.1111/j.1447-0756.2006.00455.x
  • Kim M, Kim J, Kim SM. Endometrial evaluation with transvaginal ultrasonography for the screening of endometrial hyperplasia or cancer in premenopausal and perimenopausal women. Obstet Gynecol Sci. 2016;59(3):192. doi:10.5468/ogs.2016.59.3.192
  • Van den Bosch T, Ameye L, Van Schoubroeck D, Bourne T, Timmerman D. Intra-cavitary uterine pathology in women with abnormal uterine bleeding: a prospective study of 1220 women. Facts Views Vis Obgyn. 2015;7(1):17–24.
  • Alblasa M, Velta KB, Pashayanb N, Widschwendterc M, Steyerberga EW, Yvonne V. Prediction models for endometrial cancer for the general population or symptomatic women: A systematic review. Crit Rev Oncol Hematol. 2018;126:92–99. doi:10.1016/j.critrevonc.2018.03.023
  • Kitson SJ, Evans DG, Crosbie EJ. Identifying high-risk women for endometrial cancer prevention strategies: proposal of an endometrial cancer risk prediction model. Cancer Prev Res (Phila). 2017;10(1):1–13. doi:10.1158/1940-6207.CAPR-16-0224.